A COST-EFFECTIVENESS ANALYSIS OF TACROLIMUS XL IN COMPARISON TO GENERIC TACROLIMUS FROM THE PUBLIC HEALTHCARE SECTOR IN MEXICO

被引：0
|
作者：
Anaya, P. [1 ]
de Anda, J. A. [1 ,2 ]
Salazar, A. [2 ]
Braun, S. [3 ]
机构：
[1] IMS Hlth, Mexico City, DF, Mexico
[2] IMS Hlth, Mexico City, Mexico
[3] Astellas Pharma US Inc, Northbrook, IL USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.2727
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PUK6
引用
收藏
页码：A896 / A896
页数：1
相关论文
共 50 条
  • [1] Comparison of tacrolimus with cyclosporin in kidney transplantation: Cost-minimisation and cost-effectiveness analyses
    Schindler, MT
    Klein, WH
    McKechnie, T
    [J]. VALUE IN HEALTH, 2003, 6 (06) : 704 - 704
  • [2] Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil
    Guerra Junior, Augusto Afonso
    Silva, Grazielle Dias
    Gurgel Andrade, Eli Iola
    Cherchiglia, Mariangela Leal
    Costa, Juliana de Oliveira
    Almeida, Alessandra Maciel
    Acurcio, Francisco de Assis
    [J]. REVISTA DE SAUDE PUBLICA, 2015, 49
  • [3] A cost-effectiveness analysis of tacrolimus versus cyclosporine microemulsion following kidney transplantation
    Craig, AM
    McKechnie, T
    McKenna, M
    Klein, W
    Schindler, TM
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1646 - 1648
  • [4] Network meta-analysis and cost-effectiveness analysis of infliximab, cyclosporine and tacrolimus for ulcerative colitis
    Duan, Yangyang
    Wang, Xueqi
    Li, Qiubo
    Sun, Shijiang
    Liang, Xi
    Li, Huijing
    Huang, Jing
    Zhao, Tianhe
    Hu, Jingnan
    Liu, Jianxin
    Hu, Zhenbiao
    He, Jianming
    [J]. MEDICINE, 2022, 101 (51) : E31850
  • [5] TREATMENT OF RENAL TRANSPLANTATION IN BRAZIL AFTER THE LOSS OF TACROLIMUS PATENT: A COST-EFFECTIVENESS ANALYSIS
    Saturnino, L. T. M.
    Silva, A. L.
    Acurcio, F. D. A.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A181 - A181
  • [6] COST-EFFECTIVENESS ANALYSIS OF TACROLIMUS AS PRIMARY IMMUNOSUPPRESSION FOR LUNG TRANSPLANT RECIPIENTS IN THE CZECH REPUBLIC
    Lamblova, K.
    Mlcoch, T.
    Ornstova, E.
    Dolezal, T.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A645 - A645
  • [7] COST-EFFECTIVENESS ANALYSIS OF THE EARLY CONVERSION OF TACROLIMUS TO MTOR INHIBITORS IN PATIENTS WITH RENAL TRANSPLANTATION
    Gamboa, O.
    Montero, C.
    Mesa, L.
    Benavides, C.
    Reino, A.
    Castillo, J. S.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A76 - A76
  • [8] COST-EFFECTIVENESS OF TACROLIMUS FOR THE TREATMENT OF MODERATE TO-SEVERE LUPUS NEPHRITIS
    Kim, S.
    Ooi, A. Y.
    Stephens, T. J.
    Jiang, H.
    [J]. VALUE IN HEALTH, 2018, 21 : S253 - S253
  • [9] The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation
    Garside, R
    Stein, K
    Castelnuovo, E
    Pitt, M
    Ashcroft, D
    Dimmock, P
    Payne, L
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2005, 9 (29) : 1 - +
  • [10] A NEW INSIGHT INTO COST-EFFECTIVENESS ANALYSES IN ATOPIC DERMATITIS: THE TACROLIMUS 0.1% OINTMENT VERSUS CICLOSPORIN COMPARISON
    Almeida, J.
    Vandewalle, B.
    Silva, M. J.
    Felix, J.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A570 - A571
12345